STI
49
2
CNP
70
2
FRT
45
2
AAL
16
-13
PNR
30
-2
IRM
47
3
LB
55
7
EOG
62
6
DD
41
-3
ICE
63
6
KO
47
3
GME
55
3
NOV
55
-3
ADP
39
3
CA
15
6
SHW
43
-3
HIG
54
-8
BWA
55
-5
HPQ
37
6
ALL
54
6
STI
49
2
CNP
70
2
FRT
45
2
AAL
16
-13
PNR
30
-2
IRM
47
3
LB
55
7
EOG
62
6
DD
41
-3
ICE
63
6
KO
47
3
GME
55
3
NOV
55
-3
ADP
39
3
CA
15
6
SHW
43
-3
HIG
54
-8
BWA
55
-5
HPQ
37
6
ALL
54
6
Financhill
Back

Spero Therapeutics, Inc. 10K Form

Sell
37

SPRO
Spero Therapeutics, Inc.

Last Price:
$2.44
Seasonality Move:
-9.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SPRO News And Ratings

See the #1 stock for the next 7 days that we like better than SPRO

SPRO Financial Statistics

Sales & Book Value

Annual Sales: $59.6M
Cash Flow: $-8.4M
Price / Cash Flow: 0
Annual Sales: $1.05
Price / Book: 2.38

Profitability

EPS (TTM): 0.11900
Net Income (TTM): $8.6M
Gross Margin: $0
Return on Equity: 21.62%
Return on Assets: 11.48%

Spero Therapeutics, Inc. Earnings Forecast

Key Spero Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 15 years for SPRO is 0.00%.
  • The Selling, General & Administrative Expenses for SPRO have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 64.52% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of SPRO is 14.38% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 9 years.

Spero Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SPRO
CUSIP: 84833T
Website: sperotherapeutics.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 7.59
Quick Ratio: 7.4

Price-to-Earnings

Trailing P/E Ratio: 16.74
Forward P/E Ratio: 0

SPRO Technical Analysis vs Fundamental Analysis

Sell
37
Spero Therapeutics, Inc. (SPRO) is a Sell

Is Spero Therapeutics, Inc. a Buy or a Sell?